Skip to main content
. 2022 Aug;28(8):1559–1568. doi: 10.3201/eid2808.211787

Figure 5.

Figure 5

Estimated effects of ribavirin compared with no treatment on mortality outcomes within patient subgroups in a systematic review of published and unpublished studies for evidence for ribavirin treatment of Lassa fever. *IND 16666, unpublished study requested by P.W.H. through the US Freedom of Information Act (Birch & Davis Associates and Sherikon Inc., US Army Medical Research and Development Command, unpub. data, https://media.tghn.org/medialibrary/2019/03/Responsive_Documents_of_Peter_Horby.pdf.pdf; G.V. Ludwig, pers. comm., 2019 March 4, https://media.tghn.org/medialibrary/2019/03/Dr._Ludwig_memo.pdf).